Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Optimizing Oral Targeted Anticancer Therapies Study for Patients With Solid Cancer: Protocol for a Randomized Controlled Medication Adherence Program Along With Systematic Collection and Modeling of Pharmacokinetic and Pharmacodynamic Data.
Bandiera C, Cardoso E, Locatelli I, Digklia A, Zaman K, Diciolla A, Cristina V, Stravodimou A, Veronica AL, Dolcan A, Sarivalasis A, Liapi A, Bouchaab H, Orcurto A, Dotta-Celio J, Peters S, Decosterd L, Widmer N, Wagner D, Csajka C, Schneider MP. Bandiera C, et al. JMIR Res Protoc. 2021 Jun 29;10(6):e30090. doi: 10.2196/30090. JMIR Res Protoc. 2021. PMID: 34185020 Free PMC article.
Population Pharmacokinetics of Palbociclib and Its Correlation with Clinical Efficacy and Safety in Patients with Advanced Breast Cancer.
Courlet P, Cardoso E, Bandiera C, Stravodimou A, Zurcher JP, Chtioui H, Locatelli I, Decosterd LA, Darnaud L, Blanchet B, Alexandre J, Wagner AD, Zaman K, Schneider MP, Guidi M, Csajka C. Courlet P, et al. Among authors: bandiera c. Pharmaceutics. 2022 Jun 21;14(7):1317. doi: 10.3390/pharmaceutics14071317. Pharmaceutics. 2022. PMID: 35890213 Free PMC article.
Swiss Priority Setting on Implementing Medication Adherence Interventions as Part of the European ENABLE COST Action.
Bandiera C, Ribaut J, Dima AL, Allemann SS, Molesworth K, Kalumiya K, Käser F, Olson MS, Burnier M, van Boven JFM, Szucs T, Albrecht D, Wilson I, De Geest S, Schneider MP. Bandiera C, et al. Int J Public Health. 2022 Aug 12;67:1605204. doi: 10.3389/ijph.2022.1605204. eCollection 2022. Int J Public Health. 2022. PMID: 36032275 Free PMC article. No abstract available.
Medication Adherence Evaluated Through Electronic Monitors During the 2020 COVID-19 Pandemic Lockdown in Switzerland: A Longitudinal Analysis.
Bandiera C, Pasquier J, Locatelli I, Niquille A, Wuerzner G, Dotta-Celio J, Hachfeld A, Wandeler G, Wagner AD, Csajka C, Zanchi A, Cavassini M, Schneider MP. Bandiera C, et al. Patient Prefer Adherence. 2022 Aug 25;16:2313-2320. doi: 10.2147/PPA.S377780. eCollection 2022. Patient Prefer Adherence. 2022. PMID: 36046500 Free PMC article.
Adherence to the CDK 4/6 Inhibitor Palbociclib and Omission of Dose Management Supported by Pharmacometric Modelling as Part of the OpTAT Study.
Bandiera C, Locatelli I, Courlet P, Cardoso E, Zaman K, Stravodimou A, Dolcan A, Sarivalasis A, Zurcher JP, Aedo-Lopez V, Dotta-Celio J, Peters S, Guidi M, Wagner AD, Csajka C, Schneider MP. Bandiera C, et al. Cancers (Basel). 2023 Jan 3;15(1):316. doi: 10.3390/cancers15010316. Cancers (Basel). 2023. PMID: 36612312 Free PMC article.
36 results